Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05924126

Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit

Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit: Appropriateness and Therapeutic Outcomes

Status
Recruiting
Phase
Study type
Observational
Enrollment
155 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Sepsis is one of the most common causes of ICU admission. About 5-15% of patients admitted to the hospital with an infection will have sepsis, and about 30-40% of them will have septic shock. About 34% of septic patients and about 53% of patients with septic shock will die within 28 days of admission. Broad-spectrum empiric antibiotic treatment (depending on the source of infection and patient risk factors) is one of the cornerstones of sepsis management. According to the recommendations of the surviving sepsis campaign, empiric antibiotic treatment should be given within one hour of the patient's arrival for patients with sepsis or septic shock. Administration of inappropriate antibiotics in the first 24 hours of admission was found in 34% of septic patients in various studies, and administration of inappropriate antibiotics (or when administered in delay) was found to be associated with increased morbidity and mortality. In this study, we will assess the proportion of patients who were admitted to the ICU due to sepsis or septic shock and received empiric antibiotic treatment which, in retrospect, according to the growth in the cultures later on, was inappropriate. We will also assess the therapeutic results in these patients - mainly significant morbidity and mortality within 28 days, and compare them to the group of patients who received appropriate antibiotic therapy. We would also like to assess what were the possible reasons for inappropriate empiric antibiotic treatment, in order to draw conclusions to reduce the rate of these cases.

Conditions

Interventions

TypeNameDescription
OTHERempiric antibiotic therapyseptic ICU patient given broad spectrum antibiotic therapy

Timeline

Start date
2024-01-01
Primary completion
2025-09-01
Completion
2025-09-01
First posted
2023-06-29
Last updated
2025-05-08

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT05924126. Inclusion in this directory is not an endorsement.